SCHEMBL5013104

SCHEMBL5013104

COCCN(C)c1nc2sc(C(N)=O)c(C)c2c2c1COC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 7/20 0.48
HPGD P15428 6/20 0.48
GAA P10253 3/20 0.48
MAPT P10636 3/20 0.47
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALOX15 P16050 2/20 0.41
POLB P06746 2/20 0.41
PKM P14618 1/20 0.41
CASP1 P29466 1/20 0.41
BLM P54132 1/20 0.41
CASP7 P55210 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5015905 0.77 KDM4E (0.64) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL5014733 0.74 PDE4B (0.49) KDM4EALDH1A1HPGDMAPTTDP1
SCHEMBL5013092 0.74 KDM4E (0.55) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL5011518 0.68 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL5013137 0.64 KDM4E (0.85) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL4049074 0.63 CDK8 (0.50) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL5014738 0.63 KDM4E (0.83) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL5015899 0.63 KDM4E (0.82) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL4045544 0.63 KDM4E (0.82) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL426279 0.63 KDM4E (1.00) KDM4EALDH1A1HPGDGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207645-A1 Pyridothienopyrimidine Derivatives PAGES SANTACANA LUIS MIGUEL 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207645-A1 Pyridothienopyrimidine Derivatives PDE4A, PDE5A, PDE3B KDM4E 1526/4885ALDH1A1 438/4885HPGD 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.